Follow
Evan Geller
Evan Geller
Verified email at nygenome.org
Title
Cited by
Cited by
Year
Synaptic, transcriptional and chromatin genes disrupted in autism
S De Rubeis, X He, AP Goldberg, CS Poultney, K Samocha, ...
Nature 515 (7526), 209-215, 2014
26892014
Patterns and rates of exonic de novo mutations in autism spectrum disorders
BM Neale, Y Kou, L Liu, A Ma’Ayan, KE Samocha, A Sabo, CF Lin, ...
Nature 485 (7397), 242-245, 2012
20052012
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ...
Nature genetics 43 (7), 699-705, 2011
6162011
Identification of required host factors for SARS-CoV-2 infection in human cells
Z Daniloski, TX Jordan, HH Wessels, DA Hoagland, S Kasela, M Legut, ...
Cell 184 (1), 92-105. e16, 2021
5052021
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
N Kouri, OA Ross, B Dombroski, CS Younkin, A Soto-Ortolaza, M Baker, ...
Nature communications 6 (1), 1-7, 2015
2012015
Massively parallel discovery of human-specific substitutions that alter enhancer activity
S Uebbing, J Gockley, SK Reilly, AA Kocher, E Geller, N Gandotra, ...
Proceedings of the National Academy of Sciences 118 (2), e2007049118, 2021
752021
Antisense-mediated exon skipping decreases tau protein expression: a potential therapy for tauopathies
R Sud, ET Geller, GD Schellenberg
Molecular Therapy-Nucleic Acids 3, 2014
722014
Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens
N Liscovitch-Brauer, A Montalbano, J Deng, A Méndez-Mancilla, ...
Nature biotechnology 39 (10), 1270-1277, 2021
532021
A statistical framework for mapping risk genes from de novo mutations in whole-genome-sequencing studies
Y Liu, Y Liang, AE Cicek, Z Li, J Li, RA Muhle, M Krenzer, Y Mei, Y Wang, ...
The American Journal of Human Genetics 102 (6), 1031-1047, 2018
302018
Massively parallel discovery of human-specific substitutions that alter neurodevelopmental enhancer activity
S Uebbing, J Gockley, SK Reilly, AA Kocher, E Geller, N Gandotra, ...
Biorxiv, 865519, 2019
92019
Scalable pooled CRISPR screens with single-cell chromatin accessibility profiling
N Liscovitch-Brauer, A Montalbano, J Deng, A Méndez-Mancilla, ...
BioRxiv, 2020.11. 20.390971, 2020
72020
Massively parallel disruption of enhancers active during human corticogenesis
E Geller, J Gockley, D Emera, S Uebbing, J Cotney, JP Noonan
bioRxiv, 852673, 2019
42019
Synaptic, transcriptional and chromatin genes disrupted in autism.
K Samocha, AE Cicek, L Liu, L Klei, J Kosmicki, M Biscaldi, JM Brownfeld, ...
Nature 515 (7526), 2014
42014
DRAW+ SneakPeek: Analysis workflow and quality metric management for DNA-seq experiments
CF Lin, O Valladares, DM Childress, E Klevak, ET Geller, YC Hwang, ...
Bioinformatics 29 (19), 2498-2500, 2013
42013
Contribution of de novo non-coding mutations to autism and identification of risk genes from whole-genome sequencing of affected families
Y Liu, E Cicek, Y Liang, J Li, R Muhle, N Knoblauch, M Krenzer, Y Mei, ...
bioRxiv, 077578, 2016
12016
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
NM Melhem, DW Dickson, P Sleiman, LS Wang, L Klei, R Rademakers, ...
1546-1718, 2011
12011
Massively parallel disruption of enhancers active in human neural stem cells
E Geller, MA Noble, M Morales, J Gockley, D Emera, S Uebbing, ...
Cell Reports 43 (2), 2024
2024
Massively Parallel Genetic Disruption of Enhancers Active during Human Corticogenesis
ETB Geller
Yale University, 2019
2019
P4‐440: Decline in tau levels from antisense oligo treatment: A potential curative mechanism for Alzheimer's disease
R Sud, E Geller, G Schellenberg
Alzheimer's & Dementia 7, e65-e65, 2011
2011
Contribution of de novo non-coding mutations to autism and identification of risk genes from whole-genome sequencing of affected 2 families 3
MK Knoblauch, Y Mei, Y Wang, Y Jiang, E Geller, Z Li, I Ionita-Laza11, ...
The system can't perform the operation now. Try again later.
Articles 1–20